Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route

Summary

This is a randomised, double-blind, single dose, parallel groups study to compare the PK, immunogenicity, and safety of 3 abatacept products (DRL\_AB, RP and RMP) in male NHV.

Timeline

Start

2023-10-03

Primary completion

2024-04

Completion

2024-07

Drugs

Indications